ADAM-2 (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human ADAM-2 (Fertilin β / PH-30β, UniProt Q99965) expressed in HEK293 cells. Suited for sperm-egg binding studies, integrin interaction assays, and antibody validation as a defined positive control.
Expression system
HEK293
Cat. #
REC-ADAM2

In stock

SKU
REC-ADAM2
$498.00

Target Overview

ADAM-2 (Disintegrin and metalloproteinase domain-containing protein 2; UniProt Q99965) is a 735-amino-acid sperm surface membrane protein belonging to the ADAM (a disintegrin and metalloproteinase) family. Unlike catalytically active ADAMs, ADAM-2 is a non-catalytic metalloprotease-like protein: its metalloprotease-like domain lacks key residues required for zinc-dependent proteolysis, making it a structural and adhesion-mediating subunit rather than an enzyme. The protein is best characterised as the beta subunit of the heterodimeric sperm surface complex Fertilin (PH-30), where it pairs with ADAM-1 (Fertilin α). This recombinant is produced in HEK293 mammalian cells, an expression system that supports the N-linked glycosylation patterns expected on the native sperm surface protein and promotes correct disulfide-bond formation within the disintegrin-like and cysteine-rich domains. HEK293-derived material is therefore preferred over prokaryotic expression when native-like folding or glycan-dependent binding interactions are under investigation. Researchers use this recombinant in several in-vitro contexts: (1) as a defined positive control antigen for Western blot and immunohistochemistry validation of anti-ADAM-2 antibodies, including the matched Triple Point Biologics antibody (RP-ADAM2); (2) as a binding partner in solid-phase or surface plasmon resonance assays probing integrin–disintegrin interactions on the egg surface; (3) as a reference standard in quantitative proteomics workflows characterising the sperm surface proteome; and (4) as a tool reagent for studies evaluating ADAM-2 expression changes in the context of male reproductive biology. Validated reactivity is confirmed for human; cross-reactivity with rat, pan-species, monkey, and pig material is predicted based on sequence homology.

Background

ADAM-2 (Fertilin β; PH-30β; Cancer/testis antigen 15) is a membrane-anchored, non-catalytic member of the ADAM metalloprotease superfamily expressed predominantly on the sperm surface. As the beta subunit of the Fertilin heterodimer, it has been studied for over three decades as a mediator of the key adhesion events that precede and accompany sperm–egg fusion. Its disintegrin-like domain is thought to engage integrin receptors (including α6β1 and αvβ3) on the oolemma, providing a molecular bridge that positions sperm for membrane fusion. Separately, Fertilin-containing complexes have been investigated for roles in sperm migration from the uterine lumen into the oviduct and in sperm binding to the zona pellucida, though the precise mechanistic contributions of ADAM-2 versus other ADAM family members continue to be refined in the literature. ADAM-2 is broadly classified as a cancer/testis antigen (CTA; CT15), reflecting its near-exclusive expression in normal testis among somatic tissues and its aberrant re-expression reported in certain tumour contexts — a profile that has made it a subject of investigation in reproductive oncology research. Recent published work has examined ADAM-2 expression as a potential biomarker in male infertility. Ghodrati et al. (2026) used a combined in-silico and experimental approach to evaluate miR-34a, miR-449, and ADAM2/ADAM7 transcript and protein levels in infertile versus fertile men, identifying ADAM-2 as a candidate marker whose expression correlates with sperm quality parameters (PMID: 39928278). Complementary proteomics efforts — such as surface proteome characterisation of bovine spermatozoa (Pinto-Pinho et al., 2025; PMID: 40002966) — have used mass spectrometry workflows in which recombinant reference proteins like this reagent serve as quantification anchors and antibody validation controls. Separately, Favier et al. (2025) demonstrated that a Fertilin peptide derived from the ADAM-2 disintegrin domain reduced embryo resorption and improved live birth rate in a mouse model, illustrating how recombinant ADAM-2 protein and derived peptides are applied in reproductive biology studies to interrogate specific domain functions (PMID: 40784371). Researchers investigating ADAM family redundancy in sperm function — for instance, the parallel characterisation of ADAM-5 in zona pellucida binding (Mashiko et al., 2026; PMID: 41263505) — routinely use recombinant ADAM proteins as defined reagents for antibody specificity testing and binding competition assays. This recombinant human ADAM-2 is suited to those workflows and pairs directly with the Triple Point Biologics anti-ADAM-2 antibody (RP-ADAM2) for antibody validation by Western blot or IHC.

Applications

  • Antibody validation positive control for Western blot using anti-ADAM-2 (pairs with TPB RP-ADAM2)
  • Antibody validation positive control for IHC using anti-ADAM-2 (pairs with TPB RP-ADAM2)
  • Solid-phase integrin–disintegrin binding assay to probe egg surface receptor interactions
  • Surface plasmon resonance (SPR) or bio-layer interferometry (BLI) binding kinetics with integrin ectodomains
  • Reference standard for quantitative mass spectrometry proteomics of the sperm surface proteome
  • ADAM-2 expression-level standard in male infertility biomarker studies by ELISA or Western blot
  • Competition/blocking assay to map functional epitopes on the ADAM-2 disintegrin-like domain
  • Recombinant antigen for immunisation or specificity confirmation in ADAM-family cross-reactivity panels

References

  1. Mashiko D et al. ADAM5 is required for sperm-zona pellucida binding and sperm oviduct migration. Biol Reprod. 2026. doi:10.1093/biolre/ioaf254. PMID: 41263505.
  2. Du S et al. Testis-specific gene C3ORF22/BC048671 is dispensable for spermiogenesis and male fertility. Reprod Biol. 2025. doi:10.1016/j.repbio.2025.101089. PMID: 41076814.
  3. Favier S et al. Fertilin peptide decreases embryo resorption and improves live birth rate in mouse. F S Sci. 2025. doi:10.1016/j.xfss.2025.08.001. PMID: 40784371.
  4. Pinto-Pinho P et al. The Surface Proteome of Bovine Unsexed and Sexed Spermatozoa. Animals (Basel). 2025. doi:10.3390/ani15040484. PMID: 40002966.
  5. Ghodrati F et al. Exploring miR-34a, miR-449, and ADAM2/ADAM7 Expressions as Potential Biomarkers in Male Infertility: A Combined In Silico and Experimental Approach. Biochem Genet. 2026. doi:10.1007/s10528-025-11050-1. PMID: 39928278.

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl₂, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Type I transmembrane; cell surface; Golgi → endosomes

Frequently Asked Questions

What molecular weight should I expect for recombinant ADAM-2 on SDS-PAGE or Western blot?

The ADAM-2 polypeptide backbone is 735 amino acids, giving a predicted unglycosylated MW of ~83 kDa. Because this recombinant is expressed in HEK293 cells, N-linked glycosylation adds approximately 10–20 kDa of heterogeneous glycan mass, so expect a diffuse band running at roughly 90–105 kDa under denaturing, reducing conditions. The band may appear slightly smeared rather than a sharp line — this is consistent with native glycosylation and is not a purity artefact. Purity is confirmed >95% by SDS-PAGE prior to release.

Is recombinant ADAM-2 a processed mature form or does it include the prodomain?

The recombinant ADAM-2 (REC-ADAM2) is produced as a proprotein that undergoes furin-mediated cleavage in the HEK293 secretory pathway, consistent with native ADAM processing. The released form retains the metalloprotease-like, disintegrin-like, cysteine-rich, and EGF-like ectodomains, but the prodomain is cleaved. The transmembrane anchor is absent, yielding a soluble ectodomain fragment. If your application requires the prodomain — for example, studying prodomain-mediated inhibitory interactions — this format is not appropriate and you should contact us to discuss alternatives.

Does ADAM-2 have metalloprotease enzymatic activity, and what substrate should I use in an activity assay?

ADAM-2 is non-catalytic. Its metalloprotease-like domain lacks the canonical HExxHxxGxxH zinc-chelating motif residues required for proteolysis, so it does not cleave fluorogenic peptide substrates such as Mca-RPPGFSAFK or generic quenched ADAM substrates. Do not use this recombinant in a protease activity assay expecting cleavage readout. Its functional value is structural and adhesion-mediated: it supports integrin-binding studies, fertilin heterodimer reconstitution with ADAM-1, and sperm–egg adhesion modelling. Design binding or pull-down assays, not enzymatic assays, when working with REC-ADAM2.

What buffer conditions are recommended for ADAM-2 binding or pull-down assays?

REC-ADAM2 is supplied in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol. For binding or co-immunoprecipitation assays, this buffer is a reasonable baseline. If you need to dilute into a cell-culture-compatible system, PBS pH 7.4 with 0.1% BSA works well to prevent surface adsorption at low protein concentrations. Avoid prolonged incubation below pH 6.5 or above pH 8.5, which can destabilize the disintegrin-like domain. Do not add EDTA — while ADAM-2 is non-catalytic, chelation may perturb the structural metal coordination in the metalloprotease-like fold.

How much recombinant ADAM-2 should I load as a positive control for Western blot?

For a clean positive-control lane alongside the matched antibody RP-ADAM2, load 50–100 ng of REC-ADAM2 per well on a 4–12% Bis-Tris gel. This consistently produces a detectable band at 90–105 kDa with RP-ADAM2 at standard dilutions (1:500–1:2000). Loading more than 200 ng can cause signal saturation and may obscure the glycosylation-related smear. Including this lane in every blot run is particularly useful when working with lysates from sperm or testicular tissue, where ADAM-2 expression is abundant but background can be high.

Can I use REC-ADAM2 to validate the RP-ADAM2 rabbit polyclonal antibody on Western blot?

Yes — this is one of the most straightforward uses of REC-ADAM2. The matched antibody RP-ADAM2 (/anti-adam-2-rabbit-polyclonal-antibody) was raised and validated against the same recombinant protein, so the combination gives a reliable positive-control signal at 90–105 kDa. Load 50–100 ng of REC-ADAM2, run alongside your experimental samples, and use RP-ADAM2 at 1:500–1:2000 (HRP-conjugated secondary, standard ECL detection). This pairing is also appropriate for antibody lot-to-lot consistency checks and for benchmarking new detection systems.

What is the shelf life of recombinant ADAM-2 and how should I handle it to avoid activity loss?

REC-ADAM2 is stable for at least 12 months from the date of receipt when stored at –20°C in the supplied single-use aliquots. Repeated freeze-thaw cycles degrade the disintegrin-like and cysteine-rich domains — keep aliquot sizes matched to your typical experiment volume. Once thawed, hold on ice and use within 8 hours; do not re-freeze. If you need to work at room temperature for more than 30 minutes, supplement with 0.1% BSA to reduce surface-mediated aggregation. Endotoxin is confirmed <0.1 EU/µg by LAL, so the material is suitable for cell-based adhesion assays without additional depyrogenation.

Is recombinant ADAM-2 suitable for reconstituting the Fertilin heterodimer with ADAM-1 in vitro?

REC-ADAM2 is a practical starting point for Fertilin (PH-30) heterodimer reconstitution because it is produced in HEK293 cells, which support the disulfide-bond formation and N-linked glycosylation that are required for stable ADAM-1/ADAM-2 complex assembly. Published reconstitution studies typically mix equimolar amounts of the two ectodomains (0.5–2 µM each) in PBS pH 7.4 with 0.5 mM CaCl₂ at 4°C for 2–4 hours before downstream pull-down or SPR analysis. Verify heterodimer formation by native PAGE or size-exclusion chromatography before use in adhesion or integrin-binding experiments.

Validation imagery coming soon

Western blot validation figures for REC-ADAM2 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →